2015•American Journal of Advanced Drug DeliveryRequires access

Stability Indicating RP-HPLC Method for Determination of Drotaverine HCL and Mefenamic Acid in Pure and Pharmaceutical Formulation

Pallavi A. Patil, A.R. Umarkar, Manoj M. Bari, Shashikant D. Barhate

Open publisher page 5 citations

Abstract

Objective: A Stability indicating Reverse-Phase liquid chromatographic method for the simultaneous estimation of Drotaverine HCl and Mefenamic acid was developed. Method: The chromatographic assay involves the use of Hi Q C-18 W (5µm column with a simple mobile phase containing 80:20% v/v of methanol & HPLC Grade water (0.1% triethylamine at pH 3) with flow rate of 1.0mL/min with UV detection at wavelength of 250 nm. Result: The method showed good linearity in the concentration range of 2-10 μg/mL for Drotaverine Hcl and 6-30 μg/mL for Mefenamic Acid. Conclusion: The developed method was successfully validated as per the ICH guidelines. The stability indicating capacity was also tested and successfully applied to marketed formulation.

About this research paper

What this paper is about

Objective: A Stability indicating Reverse-Phase liquid chromatographic method for the simultaneous estimation of Drotaverine HCl and Mefenamic acid was developed. Method: The chromatographic assay involves the use of Hi Q C-18 W (5µm column with a simple mobile phase containing 80:20% v/v of methanol & HPLC Grade water (0.1% triethylamine at pH 3) with flow rate of 1.0mL/min with UV detection at wavelength of 250 nm. Result: The method showed good linearity in the concentration range of 2-10 μg/mL for Drotaverine Hcl and 6-30 μg/mL for Mefenamic Acid. Conclusion: The developed method was successfully validated as per the ICH guidelines. The stability indicating capacity was also tested and successfully applied to marketed formulation.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: A Stability indicating Reverse-Phase liquid chromatographic method for the simultaneous estimation of Drotaverine HCl and Mefenamic acid was developed. Method: The chromatographic assay involves the use of Hi Q C-18 W (5µm column with a simple mobile phase containing 80:20% v/v of methanol & HPLC Grade water (0.1% triethylamine at pH 3) with flow rate of 1.0mL/min with UV detection at wavelength of 250 nm. Result: The method showed good linearity in the concentration range of 2-10 μg/mL for Drotaverine Hcl and 6-30 μg/mL for Mefenamic Acid. Conclusion: The developed method was successfully validated as per the ICH guidelines. The stability indicating capacity was also tested and successfully applied to marketed formulation.

Key concepts: Mefenamic acid, Chromatography, Triethylamine, Chemistry, High-performance liquid chromatography, Methanol, Organic chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Stability Indicating RP-HPLC Method for Determination of Drotaverine HCL and Mefenamic Acid in Pure and Pharmaceutical Formulation — Research Paper | ScholarLens